Placeholder

$4,175.00$8,175.00

Clear
SKU: N/A Category:

Global Recombinant Coagulation Factors Market Outlook (2015-2020)

Upto 20% Q4 Discount Until Jan 5th 2019.

  • Nov, 2015
  • pages: 200
  • formats:* PDF
  • Report ID: MRBT-10414

Product Description

The global recombinant coagulation factors market has witnessed major growth over the past few years. The growth of this market is mainly due to increasing number of hemophilia patients, growing diagnosis rates, and rising number of research and development on coagulation factors. In addition, increasing prophylactic treatment for hemophilia across the globe is further expected to drive the growth of this market. However, high cost of hemophilia treatment and low cost plasma coagulation factor alternatives to recombinant coagulation factors are hampering the growth of this market. Many players are focusing on Asia Pacific region to expand their businesses as this market is most lucrative for the recombinant coagulation factors.
The global recombinant coagulation factors market is expected to reach around $9,939.7 million in 2020 and grow at a CAGR of 7.6% during the forecast period of 2015 to 2020. The global market is segmented on the basis of products, by hemophilia type, and geography. On the basis of product, recombinant coagulation factors market is segmented into three classes, namely, recombinant factor VIII, recombinant factor IX, and VonWillebrandfactor. By hemophilia type, global recombinant coagulation factors market is divided into hemophilia A and hemophilia B. By end user, global recombinant coagulation factors market is segmented into hospitals and clinics, research organizations, and academic institutes.
In 2014, the recombinant factor VIII accounted for the largest share of the global recombinant coagulation factor market. The large share of this segment can be attributed to increasing number of hemophilia A patients and rising prophylaxis treatment.
In 2014, North America dominated the market, with the largest share of 37.8%. The increasing number of hemophilia patients in the U.S., increasing diagnosis rates, and growing prophylactic treatment for prevention of bleeding helped the growth of this market. In addition, rising research on recombinant factor VIII is further expected to drive the growth of this market.
Major companies in the global recombinant coagulation factor market are Baxter International Inc (U.S.), Grifols International SA (Spain), CSL Ltd. (Australia), Octapharma AG (Switzerland), Novo Nordisk A/S (Denmark), Biogen Idec (U.S.), Bayer AG (Germany),Kedrion S.P.A. (Italy), and Pfizer Inc. (U.S.).

Source: Expert Interviews, Government Authorities, Related associations/Institutes, Related Research Publications, Government Publications, Company Press Releases, Company Annual Reports, Company Websites, Company Publications, SEC Filings, Meticulous Research® Analysis.

TABLE OF CONTENTS

1 Introduction to Global Recombinant Coagulation Factors Market

1.1 Global Recombinant Coagulation Factors Market Ecosystem

1.1.1 Recombinant Coagulation Factors Market Types

1.1.2 Recombinant Coagulation Factors Market hemophilia type

1.1.3 Recombinant Coagulation Factors Market End-users

1.2 Report Elucidation

1.3 Market Buzz and Foreground

1.4 Research Methodology

2 Executive Summary

3 Market Insights

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Market Share Analysis

3.5 Recombinant Coagulation Factors Pipeline Analysis

4 Global Recombinant Coagulation Factors- Market Crackdown ($ Value Analysis), By Type

4.1 Recombinant Factor VIII

4.2 Recombinant Factor IX

4.3 VonWillebrandFractor

5 Global Recombinant Coagulation Factors- Market Crackdown ($ Value Analysis), by hemophilia type

5.1 Hemophilia A

5.2 Hemophilia B

6 Global Recombinant Coagulation Factors- Market Crackdown ($ Value Analysis), by End user

6.1 Hospitals

6.2 Research Organization

6.3 Academic Institutes

7 Recombinant Coagulation Factors – Market Crackdown ($ Value Analysis, by Geography

7.1 North America

7.1.1.1 U.S.

7.1.1.2 Canada

7.1.2 Europe

7.1.2.1 U.K.

7.1.2.2 France

7.1.2.3 Germany

7.1.2.4 Italy

7.1.2.5 Spain

7.1.2.6 Rest of Europe

7.1.3 Asia-Pacific

7.1.3.1 China

7.1.3.2 Japan

7.1.3.3 India

7.1.3.4 Rest of Asia-Pacific

7.1.4 RoW

7.1.4.1 Latin America

7.1.4.2 Africa

7.1.4.3 Middle East

8 Global Recombinant Coagulation Factors Market- Competitive Landscape

8.1 Agreements, Collaborations, Partnerships, and Joint Ventures

8.2 Expansions

8.3 Mergers & Acquisitions

8.4 New Product Launches

8.5 Other Developments

9 Company Profiles

9.1 Baxter International Inc

9.1.1 Company Overview

9.1.2 Financials

9.1.3 Products & Services

9.1.4 Recent Developments

9.2 Grifols International SA

9.2.1 Company Overview

9.2.2 Financials

9.2.3 Products & Services

9.2.4 Recent Developments

9.3 CSL Ltd.

9.3.1 Company Overview

9.3.2 Financials

9.3.3 Products & Services

9.3.4 Recent Developments

9.4 Octapharma AG

9.4.1 Company Overview

9.4.2 Financials

9.4.3 Products & Services

9.4.4 Recent Developments

9.5 Kedrion S.P.A.

9.5.1 Company Overview

9.5.2 Financials

9.5.3 Products & Services

9.5.4 Recent Developments

9.6 Novo Nordisk A/S

9.6.1 Company Overview

9.6.2 Financials

9.6.3 Products & Services

9.6.4 Recent Developments

9.7 Pfizer Inc

9.7.1 Company Overview

9.7.2 Financials

9.7.3 Products & Services

9.7.4 Recent Developments

9.8 Bayer AG

9.8.1 Company Overview

9.8.2 Financials

9.8.3 Products & Services

9.8.4 Recent Developments

9.9 Biogen Idec

9.9.1 Company Overview

9.9.2 Financials

9.9.3 Products & Services

9.9.4 Recent Developments

LIST OF TABLES & FIGURES

List of Tables

Table 1 Global Recombinant Coagulation Factor Market Size, By Product,Through 2020 ($Million)
Table 2 Global Recombinant Coagulation Factor Market Size, By Geography, Through 2020 ($Million)
Table 3 Global Recombinant Factor VIII Market Size, By Country/Region, Through 2020 ($Million)
Table 4 Global Recombinant Factor IX Market Size, By Country/Region, Through 2020 ($Million)
Table 5 Global Von Willebrand factor Market Size, By Country/Region, Through 2020 ($Million)
Table 6 Global Recombinant Coagulation Factor Market Size, By Hemophilia Type, Through 2020 ($Million)
Table 7 Global Recombinant Coagulation Factor Market Size, By Geography, Through 2020 ($Million)
Table 8 Global Recombinant Coagulation Factor Market Size, For Hemophilia A, Through 2020 ($Million)
Table 9 Global Recombinant Coagulation Factor Market Size, For Hemophilia B, Through 2020 ($Million)
Table 10 Global Recombinant Coagulation Factor Market Size, By end-user, Through 2020 ($Million)
Table 11 Global Recombinant Coagulation Factor For Hospitals And Clinics, By Country/Region, Through 2020 ($Million) )
Table 12 Global Recombinant Coagulation Factor For Research Organizations, By Country/Region, Through 2020 ($Million)
Table 13 Global Recombinant Coagulation Factor For Academic Institutes, By Country/Region, Through 2020 ($Million)
Table 14 North America: Recombinant Coagulation Factor Market Size, By Country, Through 2020 ($Million)
Table 15 North America: Recombinant Coagulation Factor Market Size, By Products, Through 2020 ($Million)
Table 16 North America: Recombinant Coagulation Factor Market Size, By Hemophilia Type, Through 2020 ($Million)
Table 17 North America: Recombinant Coagulation Factor Market, By End User, Through 2020 ($Million)
Table 18 U.S.: Plasma Fractionation Market Size, By Products, Through 2020 ($Million)
Table 19 U.S.: Recombinant Coagulation Factor Market Size, By Product, Through 2020 ($Million)
Table 20 U.S.: Recombinant Coagulation Factor Market Size, By Hemophilia Type, Through 2020 ($Million)
Table 21 U.S.: Recombinant Coagulation Factor Market Size, By End User, Through 2020 ($Million)
Table 22 Canada: Recombinant Coagulation Factor Market Size, By Products, Through 2020 ($Million)
Table 23 Canada: Recombinant Coagulation Factor Market Size, By Hemophilia Type, Through 2020 ($Million)
Table 24 Canada: Recombinant Coagulation Factor Market Size, By End Users, Through 2020 ($Million)
Table 25 Europe: Recombinant Coagulation Factor Market Size, By Country/Region, Through 2020 ($Million)
Table 26 Europe: Recombinant Coagulation Factor Market Size, By Products, Through 2020 ($Million)
Table 27 Europe: Recombinant Coagulation Factor Market Size, By Hemophilia Type, Through 2020 ($Million)
Table 28 Europe: Recombinant Coagulation Factor Market Size, By End Users, Through 2020 ($Million)
Table 29 Germany: Recombinant Coagulation Factor Market Size, By Products, Through 2020 ($Million)
Table 30 Germany: Recombinant Coagulation Factor Market Size, By Hemophilia Type, Through 2020 ($Million)
Table 31 Germany: Recombinant Coagulation Factor Market Size, By End Users, Through 2020 ($Million)
Table 32 U.K.: Recombinant Coagulation Factor Market Size, By Products, Through 2020 ($Million)
Table 33 U.K.: Recombinant Coagulation Factor Market Size, By Hemophilia Type , Through 2020 ($Million)
Table 34 U.K.: Recombinant Coagulation Factor Market Size, By End Users, Through 2020 ($Million)
Table 35 France: Recombinant Coagulation Factor Market Size, By Products, Through 2020 ($Million)
Table 36 France: Recombinant Coagulation Factor Market Size, By Hemophilia Type , Through 2020 ($Million)
Table 37 France: Recombinant Coagulation Factor Market Size, By End Users, Through 2020 ($Million)
Table 38 Italy: Recombinant Coagulation Factor Market Size, By Products, Through 2020 ($Million)
Table 39 Italy: Recombinant Coagulation Factor Market Size, By Hemophilia Type , Through 2020 ($Million)
Table 40 Italy: Recombinant Coagulation Factor Market Size, By End Users, Through 2020 ($Million)
Table 41 Spain: Recombinant Coagulation Factor Market Size, By Products, Through 2020 ($Million)
Table 42 Spain: Recombinant Coagulation Factor Market Size, By Hemophilia Type , Through 2020 ($Million)
Table 43 Spain: Recombinant Coagulation Factor Market Size, By End Users, 2015-2020 ($Million)
Table 44 ROE: Recombinant Coagulation Factor Market Size, By Products, 2015-2020 ($Million)
Table 45 ROE: Recombinant Coagulation Factor Market Size, By Hemophilia Type , 2015-2020 ($Million)
Table 46 ROE: Recombinant Coagulation Factor Market Size, By End Users, Through 2020 ($Million)
Table 47 Asia-Pacific: Recombinant Coagulation Factor Market Size, By Country/Region, Through 2020 ($Million)
Table 48 Asia-Pacific: Recombinant Coagulation Factor Market Size, By Products, Through 2020 ($Million)
Table 49 Asia-Pacific: Recombinant Coagulation Factor Market Size, By Hemophilia Type , Through 2020 ($Million)
Table 50 Asia-Pacific: Recombinant Coagulation Factor Market Size, By End Users, Through 2020 ($Million)
Table 51 Japan: Recombinant Coagulation Factor Market Size, By Products, Through 2020 ($Million)
Table 52 Japan: Recombinant Coagulation Factor Market Size, By Hemophilia Type , Through 2020 ($Million)
Table 53 Japan: Recombinant Coagulation Factor Market Size, By End Users, Through 2020 ($Million)
Table 54 China: Recombinant Coagulation Factor Market Size, By Products, Through 2020 ($Million)
Table 55 China: Recombinant Coagulation Factor Market Size, By Hemophilia Type , Through 2020 ($Million)
Table 56 China: Recombinant Coagulation Factor Market Size, By End Users, Through 2020 ($Million)
Table 57 India: Recombinant Coagulation Factor Market Size, By Products, Through 2020 ($Million)
Table 58 India: Recombinant Coagulation Factor Market Size, By Hemophilia Type , Through 2020 ($Million)
Table 59 India: Recombinant Coagulation Factor Market Size, By End Users, Through 2020 ($Million)
Table 60 Rest Of Asia-Pacific: Recombinant Coagulation Factor Market Size, By Products, Through 2020 ($Million)
Table 61 Rest Of Asia-Pacific: Recombinant Coagulation Factor Market Size, By Hemophilia Type, Through 2020 ($Million)
Table 62 Rest Of Asia-Pacific: Recombinant Coagulation Factor Market Size, By End User,Through 2020 ($Million)
Table 63 ROW: Recombinant Coagulation Factor Market Size, By Country/Region, 2015-2020 ($Million)
Table 64 ROW: Recombinant Coagulation Factor Market Size, By Products, Through 2020 ($Million)
Table 65 ROW: Recombinant Coagulation Factor Market Size, By Hemophilia Type, Through 2020 ($Million)
Table 66 ROW: Recombinant Coagulation Factor Market Size, By End User, Through 2020 ($Million)
Table 67 Latin America: Recombinant Coagulation Factor Market Size, By Products, Through 2020 ($Million)
Table 68 Latin America: Recombinant Coagulation Factor Market Size, By Hemophilia Type , Through 2020 ($Million)
Table 69 Latin America: Recombinant Coagulation Factor Market Size, By End User, Through 2020 ($Million)
Table 70 Middle East & Africa: Recombinant Coagulation Factor Market Size, By Products, Through 2020 ($Million)
Table 71 Middle East & Africa: Recombinant Coagulation Factor Market Size, By Hemophilia Type,Through 2020 ($Million)
Table 72 Middle East & Africa: Recombinant Coagulation Factor Market Size, By End User, Through 2020 ($Million)
Table 72 New Product Launches, 2012–2015
Table 73 Expansions, 2012–2015
Table 74 Mergers And Acquisitions, 2012–2015
Table 75 Agreements, Partnerships, Collaborations, And Joint Ventures, 2012–2015

List of Figures

Figure 1 Recombinant Coagulation Factor VIII will dominate the market
Figure 2 Hemophilia A will dominate the Global Recombinant Coagulation Market
Figure 3 Hospital and Clinics will dominate the Global Recombinant Coagulation Market
Figure 4 Baxter International Inc.: Financial Detail
Figure 5 Octapharma AG: Financial Detail
Figure 6 Bayer AG: Financial Detail
Figure 7 CSL Ltd.: Financial Detail
Figure 8 Grifols International SA: Financial Detail
Figure 9 Kedrion S.P.A.: Financial Detail
Figure 10 Novo Nordisk A/S: Financial Detail
Figure 12 Biogen Idec: Financial Detail
Figure 13 Pfizer Inc. : Financial Detail

DOWNLOAD SAMPLE

Download Sample

Please fill in the form below to receive the free sample pages of the report.

This website is secure and we do not share your personal information with any third party. Privacy Policy

NEED CUSTOMIZATION?

Need Customization?

Not satisfied with the defined report scope. No worries, we can customize this report for you.
Please fill in the form below and our research analyst will get in touch with you immediately.

This website is secure and we do not share your personal information with any third party. Privacy Policy

Reviews

There are no reviews yet.

Be the first to review “Global Recombinant Coagulation Factors Market Outlook (2015-2020)”